Title : Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management.

Pub. Date : 2022

PMID : 35221836






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The currently available HMG-R inhibitors (statins) and PCSK-9 inhibitors (siRNA, anti-sense oligonucleotides, and monoclonal antibodies) have shown great promises in achieving LDL-C lowering goals, however, their life long prescriptions have raised significant concerns. Oligonucleotides proprotein convertase subtilisin/kexin type 9 Homo sapiens